Substituted annulated triazines and use thereof

US9505786B2 · kind B2 · utility

Assignees

• Bayer Pharma Aktiengesellschaft · DE
• Bayer Intellectual Property GmbH · DE

Inventors

• Markus Follmann
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Nils Griebenow · Milford, US
• Dieter Lang · Velbert, DE
• Frank Wunder · Wuppertal, DE
• Walter Hubsch · Wuppertal, DE
• Alexandros Vakalopoulos · Hilden, DE
• Adrian Tersteegen · Wuppertal, DE

Key dates

• Filing date: Jun 12, 2015
• Grant date: Nov 29, 2016
• Expiry date: Jun 12, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted fused pyrimidines and triazines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.